Listed

Outset Medical, Inc.

OMNasdaqCIK 1484612HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$31.6m, Q2 FY2026
Operating income−$15.7m, Q2 FY2026
Net income−$18.0m, Q2 FY2026
Outset Medical, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m30.4Revenue, Q3 FY2023, three months to 2023-09-30$30.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figure30.5Revenue, Q4 FY2023, three months to 2023-12-31$30.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure28.2Revenue, Q1 FY2024, three months to 2024-03-31$28.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0000950170-25-066003.Report this figure27.4Revenue, Q2 FY2024, three months to 2024-06-30$27.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0000950170-25-104300.Report this figure28.7Revenue, Q3 FY2024, three months to 2024-09-30$28.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure29.5Revenue, Q4 FY2024, three months to 2024-12-31$29.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure29.8Revenue, Q1 FY2025, three months to 2025-03-31$29.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure31.4Revenue, Q2 FY2025, three months to 2025-06-30$31.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure29.4Revenue, Q3 FY2025, three months to 2025-09-30$29.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure28.9Revenue, Q4 FY2025, three months to 2025-12-31$28.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure27.9Revenue, Q1 FY2026, three months to 2026-03-31$27.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure31.6Revenue, Q2 FY2026, three months to 2026-06-30$31.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure
Cost of revenue$m23.2Cost of revenue, Q3 FY2023, three months to 2023-09-30$23.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figure22.8Cost of revenue, Q4 FY2023, three months to 2023-12-31$22.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure20.0Cost of revenue, Q1 FY2024, three months to 2024-03-31$20.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-08, accession 0000950170-25-066003.Report this figure17.6Cost of revenue, Q2 FY2024, three months to 2024-06-30$17.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-07, accession 0000950170-25-104300.Report this figure18.8Cost of revenue, Q3 FY2024, three months to 2024-09-30$18.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure18.7Cost of revenue, Q4 FY2024, three months to 2024-12-31$18.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure18.7Cost of revenue, Q1 FY2025, three months to 2025-03-31$18.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure19.6Cost of revenue, Q2 FY2025, three months to 2025-06-30$19.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure17.8Cost of revenue, Q3 FY2025, three months to 2025-09-30$17.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure16.6Cost of revenue, Q4 FY2025, three months to 2025-12-31$16.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure15.8Cost of revenue, Q1 FY2026, three months to 2026-03-31$15.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure18.4Cost of revenue, Q2 FY2026, three months to 2026-06-30$18.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure
Gross profit$m7.2Gross profit, Q3 FY2023, three months to 2023-09-30$7.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figure7.7Gross profit, Q4 FY2023, three months to 2023-12-31$7.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure8.2Gross profit, Q1 FY2024, three months to 2024-03-31$8.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-08, accession 0000950170-25-066003.Report this figure9.8Gross profit, Q2 FY2024, three months to 2024-06-30$9.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-07, accession 0000950170-25-104300.Report this figure9.8Gross profit, Q3 FY2024, three months to 2024-09-30$9.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure10.7Gross profit, Q4 FY2024, three months to 2024-12-31$10.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure11.1Gross profit, Q1 FY2025, three months to 2025-03-31$11.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure11.9Gross profit, Q2 FY2025, three months to 2025-06-30$11.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure11.6Gross profit, Q3 FY2025, three months to 2025-09-30$11.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure12.2Gross profit, Q4 FY2025, three months to 2025-12-31$12.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure12.1Gross profit, Q1 FY2026, three months to 2026-03-31$12.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure13.3Gross profit, Q2 FY2026, three months to 2026-06-30$13.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure
Research and development$m16.1Research and development, Q3 FY2023, three months to 2023-09-30$16.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figure12.5Research and development, Q4 FY2023, three months to 2023-12-31$12.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure12.6Research and development, Q1 FY2024, three months to 2024-03-31$12.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066003.Report this figure9.7Research and development, Q2 FY2024, three months to 2024-06-30$9.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104300.Report this figure8.1Research and development, Q3 FY2024, three months to 2024-09-30$8.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure7.9Research and development, Q4 FY2024, three months to 2024-12-31$7.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure5.5Research and development, Q1 FY2025, three months to 2025-03-31$5.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure5.3Research and development, Q2 FY2025, three months to 2025-06-30$5.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure5.4Research and development, Q3 FY2025, three months to 2025-09-30$5.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure5.1Research and development, Q4 FY2025, three months to 2025-12-31$5.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure5.6Research and development, Q1 FY2026, three months to 2026-03-31$5.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure5.5Research and development, Q2 FY2026, three months to 2026-06-30$5.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure
Operating income$m(45.5)Operating income, Q3 FY2023, three months to 2023-09-30−$45.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figure(37.4)Operating income, Q4 FY2023, three months to 2023-12-31−$37.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure(36.9)Operating income, Q1 FY2024, three months to 2024-03-31−$36.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066003.Report this figure(30.8)Operating income, Q2 FY2024, three months to 2024-06-30−$30.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-104300.Report this figure(23.8)Operating income, Q3 FY2024, three months to 2024-09-30−$23.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure(21.9)Operating income, Q4 FY2024, three months to 2024-12-31−$21.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure(16.4)Operating income, Q1 FY2025, three months to 2025-03-31−$16.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure(16.9)Operating income, Q2 FY2025, three months to 2025-06-30−$16.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure(15.8)Operating income, Q3 FY2025, three months to 2025-09-30−$15.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure(17.6)Operating income, Q4 FY2025, three months to 2025-12-31−$17.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure(16.9)Operating income, Q1 FY2026, three months to 2026-03-31−$16.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure(15.7)Operating income, Q2 FY2026, three months to 2026-06-30−$15.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure
Interest expense$m3.2Interest expense, Q3 FY2023, three months to 2023-09-30$3.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figure3.4Interest expense, Q4 FY2023, three months to 2023-12-31$3.4m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure6.0Interest expense, Q1 FY2024, three months to 2024-03-31$6.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066003.Report this figure6.0Interest expense, Q2 FY2024, three months to 2024-06-30$6.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104300.Report this figure6.1Interest expense, Q3 FY2024, three months to 2024-09-30$6.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure5.8Interest expense, Q4 FY2024, three months to 2024-12-31$5.8m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure3.6Interest expense, Q1 FY2025, three months to 2025-03-31$3.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure3.5Interest expense, Q2 FY2025, three months to 2025-06-30$3.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure3.5Interest expense, Q3 FY2025, three months to 2025-09-30$3.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure3.4Interest expense, Q4 FY2025, three months to 2025-12-31$3.4m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure3.4Interest expense, Q1 FY2026, three months to 2026-03-31$3.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure3.4Interest expense, Q2 FY2026, three months to 2026-06-30$3.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure
Income tax$m0.1Income tax, Q3 FY2023, three months to 2023-09-30$86.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figure0.1Income tax, Q4 FY2023, three months to 2023-12-31$112.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure0.2Income tax, Q1 FY2024, three months to 2024-03-31$162.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0000950170-25-066003.Report this figure0.2Income tax, Q2 FY2024, three months to 2024-06-30$151.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000950170-25-104300.Report this figure0.2Income tax, Q3 FY2024, three months to 2024-09-30$182.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure(0.0)Income tax, Q4 FY2024, three months to 2024-12-31−$4.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2025, three months to 2025-03-31$115.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure0.1Income tax, Q2 FY2025, three months to 2025-06-30$104.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure0.4Income tax, Q3 FY2025, three months to 2025-09-30$404.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure0.1Income tax, Q4 FY2025, three months to 2025-12-31$95.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure0.2Income tax, Q1 FY2026, three months to 2026-03-31$217.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure0.2Income tax, Q2 FY2026, three months to 2026-06-30$220.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure
Net income$m(46.2)Net income, Q3 FY2023, three months to 2023-09-30−$46.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figure(38.6)Net income, Q4 FY2023, three months to 2023-12-31−$38.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure(39.9)Net income, Q1 FY2024, three months to 2024-03-31−$39.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure(34.5)Net income, Q2 FY2024, three months to 2024-06-30−$34.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure(27.9)Net income, Q3 FY2024, three months to 2024-09-30−$27.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure(25.6)Net income, Q4 FY2024, three months to 2024-12-31−$25.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure(25.8)Net income, Q1 FY2025, three months to 2025-03-31−$25.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure(18.5)Net income, Q2 FY2025, three months to 2025-06-30−$18.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure(17.8)Net income, Q3 FY2025, three months to 2025-09-30−$17.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure(19.5)Net income, Q4 FY2025, three months to 2025-12-31−$19.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure(19.0)Net income, Q1 FY2026, three months to 2026-03-31−$19.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure(18.0)Net income, Q2 FY2026, three months to 2026-06-30−$18.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure
Diluted EPS$ per share(0.93)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figurenot reported(11.77)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$11.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-066003.Report this figure(9.96)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$9.96 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-104300.Report this figure(8.02)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$8.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figurenot reported(3.66)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$3.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure(1.04)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure(1.00)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figurenot reported(1.03)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure(0.97)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.97 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure
Basic EPS$ per share(0.93)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.93 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figurenot reported(11.77)Basic EPS, Q1 FY2024, three months to 2024-03-31−$11.77 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-066003.Report this figure(9.96)Basic EPS, Q2 FY2024, three months to 2024-06-30−$9.96 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-104300.Report this figure(8.02)Basic EPS, Q3 FY2024, three months to 2024-09-30−$8.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figurenot reported(3.66)Basic EPS, Q1 FY2025, three months to 2025-03-31−$3.66 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure(1.04)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure(1.00)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figurenot reported(1.03)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure(0.97)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.97 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure

Balance sheet

Cash and equivalents$35.0m, Q2 FY2026
Long-term debt$97.6m, Q2 FY2026
Shareholders' equity$96.3m, Q2 FY2026
Outset Medical, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m36.3Cash and equivalents, Q3 FY2023, at 2023-09-30$36.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figure68.5Cash and equivalents, FY2023, at 2023-12-31$68.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-28, accession 0000950170-25-030045.Report this figure32.2Cash and equivalents, Q1 FY2024, at 2024-03-31$32.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0000950170-24-055981.Report this figure37.9Cash and equivalents, Q2 FY2024, at 2024-06-30$37.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-093071.Report this figure33.3Cash and equivalents, Q3 FY2024, at 2024-09-30$33.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figure124Cash and equivalents, FY2024, at 2024-12-31$124.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-13, accession 0001193125-26-051278.Report this figure75.9Cash and equivalents, Q1 FY2025, at 2025-03-31$75.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066003.Report this figure39.6Cash and equivalents, Q2 FY2025, at 2025-06-30$39.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-104300.Report this figure36.4Cash and equivalents, Q3 FY2025, at 2025-09-30$36.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure35.0Cash and equivalents, FY2025, at 2025-12-31$35.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure30.6Cash and equivalents, Q1 FY2026, at 2026-03-31$30.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure35.0Cash and equivalents, Q2 FY2026, at 2026-06-30$35.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure
Current assets$m284Current assets, Q3 FY2023, at 2023-09-30$283.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-060476.Report this figure291Current assets, FY2023, at 2023-12-31$291.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-28, accession 0000950170-25-030045.Report this figure325Current assets, Q1 FY2024, at 2024-03-31$325.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-055981.Report this figure295Current assets, Q2 FY2024, at 2024-06-30$295.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093071.Report this figure275Current assets, Q3 FY2024, at 2024-09-30$275.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figure258Current assets, FY2024, at 2024-12-31$258.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-13, accession 0001193125-26-051278.Report this figure287Current assets, Q1 FY2025, at 2025-03-31$286.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066003.Report this figure276Current assets, Q2 FY2025, at 2025-06-30$275.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104300.Report this figure265Current assets, Q3 FY2025, at 2025-09-30$265.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure251Current assets, FY2025, at 2025-12-31$250.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure237Current assets, Q1 FY2026, at 2026-03-31$236.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure228Current assets, Q2 FY2026, at 2026-06-30$227.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure
Total assets$m308Total assets, Q3 FY2023, at 2023-09-30$307.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0000950170-23-060476.Report this figure314Total assets, FY2023, at 2023-12-31$313.8m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-28, accession 0000950170-25-030045.Report this figure346Total assets, Q1 FY2024, at 2024-03-31$346.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-055981.Report this figure315Total assets, Q2 FY2024, at 2024-06-30$314.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093071.Report this figure293Total assets, Q3 FY2024, at 2024-09-30$292.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figure276Total assets, FY2024, at 2024-12-31$275.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-13, accession 0001193125-26-051278.Report this figure301Total assets, Q1 FY2025, at 2025-03-31$301.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-066003.Report this figure289Total assets, Q2 FY2025, at 2025-06-30$288.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-104300.Report this figure277Total assets, Q3 FY2025, at 2025-09-30$277.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure264Total assets, FY2025, at 2025-12-31$264.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure249Total assets, Q1 FY2026, at 2026-03-31$249.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure242Total assets, Q2 FY2026, at 2026-06-30$242.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure
Current liabilities$m53.0Current liabilities, Q3 FY2023, at 2023-09-30$53.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-060476.Report this figure55.3Current liabilities, FY2023, at 2023-12-31$55.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-28, accession 0000950170-25-030045.Report this figure50.7Current liabilities, Q1 FY2024, at 2024-03-31$50.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-055981.Report this figure43.4Current liabilities, Q2 FY2024, at 2024-06-30$43.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093071.Report this figure42.4Current liabilities, Q3 FY2024, at 2024-09-30$42.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figure45.4Current liabilities, FY2024, at 2024-12-31$45.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-13, accession 0001193125-26-051278.Report this figure34.2Current liabilities, Q1 FY2025, at 2025-03-31$34.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066003.Report this figure36.9Current liabilities, Q2 FY2025, at 2025-06-30$36.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104300.Report this figure37.4Current liabilities, Q3 FY2025, at 2025-09-30$37.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure37.6Current liabilities, FY2025, at 2025-12-31$37.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure37.6Current liabilities, Q1 FY2026, at 2026-03-31$37.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure43.9Current liabilities, Q2 FY2026, at 2026-06-30$43.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure
Total liabilities$m155Total liabilities, Q3 FY2023, at 2023-09-30$155.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0000950170-23-060476.Report this figure191Total liabilities, FY2023, at 2023-12-31$190.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-28, accession 0000950170-25-030045.Report this figure253Total liabilities, Q1 FY2024, at 2024-03-31$253.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-055981.Report this figure246Total liabilities, Q2 FY2024, at 2024-06-30$245.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093071.Report this figure245Total liabilities, Q3 FY2024, at 2024-09-30$245.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figure249Total liabilities, FY2024, at 2024-12-31$249.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-13, accession 0001193125-26-051278.Report this figure131Total liabilities, Q1 FY2025, at 2025-03-31$131.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-066003.Report this figure134Total liabilities, Q2 FY2025, at 2025-06-30$134.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-104300.Report this figure135Total liabilities, Q3 FY2025, at 2025-09-30$134.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure138Total liabilities, FY2025, at 2025-12-31$137.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure138Total liabilities, Q1 FY2026, at 2026-03-31$137.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure146Total liabilities, Q2 FY2026, at 2026-06-30$146.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure
Long-term debt$m96.8Long-term debt, Q3 FY2023, at 2023-09-30$96.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-08, accession 0000950170-23-060476.Report this figure130Long-term debt, FY2023, at 2023-12-31$130.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-28, accession 0000950170-25-030045.Report this figure197Long-term debt, Q1 FY2024, at 2024-03-31$196.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-09, accession 0000950170-24-055981.Report this figure197Long-term debt, Q2 FY2024, at 2024-06-30$197.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093071.Report this figure197Long-term debt, Q3 FY2024, at 2024-09-30$197.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figure197Long-term debt, FY2024, at 2024-12-31$197.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-13, accession 0001193125-26-051278.Report this figure94.1Long-term debt, Q1 FY2025, at 2025-03-31$94.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066003.Report this figure94.8Long-term debt, Q2 FY2025, at 2025-06-30$94.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104300.Report this figure95.5Long-term debt, Q3 FY2025, at 2025-09-30$95.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure96.2Long-term debt, FY2025, at 2025-12-31$96.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure96.9Long-term debt, Q1 FY2026, at 2026-03-31$96.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure97.6Long-term debt, Q2 FY2026, at 2026-06-30$97.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m152Shareholders' equity, Q3 FY2023, at 2023-09-30$152.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figure123Shareholders' equity, FY2023, at 2023-12-31$122.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-13, accession 0001193125-26-051278.Report this figure93.2Shareholders' equity, Q1 FY2024, at 2024-03-31$93.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure68.6Shareholders' equity, Q2 FY2024, at 2024-06-30$68.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure47.8Shareholders' equity, Q3 FY2024, at 2024-09-30$47.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure26.8Shareholders' equity, FY2024, at 2024-12-31$26.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure170Shareholders' equity, Q1 FY2025, at 2025-03-31$169.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure155Shareholders' equity, Q2 FY2025, at 2025-06-30$154.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure142Shareholders' equity, Q3 FY2025, at 2025-09-30$142.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure127Shareholders' equity, FY2025, at 2025-12-31$127.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure112Shareholders' equity, Q1 FY2026, at 2026-03-31$111.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure96.3Shareholders' equity, Q2 FY2026, at 2026-06-30$96.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure

Cash flow

Operating cash flow−$9.6m, Q2 FY2026
Capital expenditure$111.0k, Q2 FY2026
Outset Medical, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(34.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$34.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-122518. Derived: 9-month figure less the 6-month figure.Report this figure(24.4)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$24.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure(45.9)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$45.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-066003.Report this figure(33.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$33.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-104300. Derived: 6-month figure less the 3-month figure.Report this figure(20.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$20.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-274504. Derived: 9-month figure less the 6-month figure.Report this figure(16.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$16.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure(25.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$25.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure(4.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$4.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338432. Derived: 6-month figure less the 3-month figure.Report this figure(6.3)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$6.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-274504. Derived: 9-month figure less the 6-month figure.Report this figure(9.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$9.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure(12.8)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$12.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure(9.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$9.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338432. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.8Capital expenditure, Q3 FY2023, three months to 2023-09-30$782.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-122518. Derived: 9-month figure less the 6-month figure.Report this figure1.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure0.4Capital expenditure, Q1 FY2024, three months to 2024-03-31$354.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000950170-25-066003.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$120.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-104300. Derived: 6-month figure less the 3-month figure.Report this figure0.4Capital expenditure, Q3 FY2024, three months to 2024-09-30$395.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-274504. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$43.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$123.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure0.3Capital expenditure, Q2 FY2025, three months to 2025-06-30$292.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338432. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$160.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-274504. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$223.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0001193125-26-051278. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$65.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$111.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338432. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)18,619, Q2 FY2026
Outset Medical, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)k shares48.1Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3048,129 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0000950170-23-060476.Report this figure48.8Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3148,783 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000950170-24-055981.Report this figure49.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3048,951 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-093071.Report this figure49.9Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3049,913 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-122518.Report this figure3.4Diluted shares (weighted), Q1 FY2024, three months to 2024-03-313,393 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-066003.Report this figure3.5Diluted shares (weighted), Q2 FY2024, three months to 2024-06-303,458 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-104300.Report this figure3.5Diluted shares (weighted), Q3 FY2024, three months to 2024-09-303,484 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure7.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-317,038 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure17.7Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3017,743 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure17.8Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3017,783 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001193125-25-274504.Report this figure18.4Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3118,373 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-212481.Report this figure18.6Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3018,619 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure

Shares outstanding: 18.80mShares outstanding, period not labelled, at 2026-08-0418,797,164 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338432.Report this figure at Aug 4, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. Listed shows no prices and gives no investment advice.